Related references
Note: Only part of the references are listed.Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida et al.
CLINICAL CANCER RESEARCH (2020)
Functionally Enigmatic Genes in Cancer: Using TCGA Data to Map the Limitations of Annotations
Alexandra Maertens et al.
SCIENTIFIC REPORTS (2020)
Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley et al.
CANCER (2020)
Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive for Prostate Cancer
Konrad H. Stopsack et al.
CLINICAL CANCER RESEARCH (2020)
A genomic and epigenomic atlas of prostate cancer in Asian populations
Jing Li et al.
NATURE (2020)
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
Yusuke Koga et al.
CLINICAL CANCER RESEARCH (2020)
Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer
Umang Swami et al.
EUROPEAN UROLOGY (2020)
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors
Emmanuel S. Antonarakis et al.
JCO PRECISION ONCOLOGY (2020)
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples
Sally E. Trabucco et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012
Maha Hussain et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity
Gunther Boysen et al.
CLINICAL CANCER RESEARCH (2018)
Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study
Andreas Thorstenson et al.
JOURNAL OF UROLOGY (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States
Jim C. Hu et al.
JAMA ONCOLOGY (2017)
Genomes of early onset prostate cancer
Joachim Weischenfeldt et al.
CURRENT OPINION IN UROLOGY (2017)
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
Christine Henzler et al.
NATURE COMMUNICATIONS (2016)
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
Nada Lallous et al.
GENOME BIOLOGY (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
Francesca Khani et al.
CLINICAL CANCER RESEARCH (2014)
Prostate cancer in young men: an important clinical entity
Claudia A. Salinas et al.
NATURE REVIEWS UROLOGY (2014)
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Joachim Weischenfeldt et al.
CANCER CELL (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Early onset prostate cancer has a significant genetic component
Ethan M. Lange et al.
PROSTATE (2012)
Common Gene Rearrangements in Prostate Cancer
Mark A. Rubin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Treatment and Survival Outcomes in Young Men Diagnosed With Prostate Cancer
Daniel W. Lin et al.
CANCER (2009)
Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
Juan-Miguel Mosquera et al.
CLINICAL CANCER RESEARCH (2009)
ETS gene fusions in prostate cancer
Jeremy P. Clark et al.
NATURE REVIEWS UROLOGY (2009)
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
Liesel M. FitzGerald et al.
BMC CANCER (2008)
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer
Rohit Mehra et al.
CANCER RESEARCH (2008)
Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study
Simon M. Collin et al.
LANCET ONCOLOGY (2008)
Quantifying the role of PSA screening in the US prostate cancer mortality decline
Ruth Etzioni et al.
CANCER CAUSES & CONTROL (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
TMPRSS2-ETS fusion prostate cancer: Biological and clinical implications
Francesca Demichelis et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Share Paper
